Concentra Group (NYSE: CON) shares preliminary Q4 2025 metrics via presentation

Rhea-AI Filing Summary

Concentra Group Holdings Parent, Inc. furnished an investor presentation containing preliminary, unaudited operational metrics for the quarter ended December 31, 2025. The presentation, filed as Exhibit 99.1, will be used at the J.P. Morgan Healthcare Conference at 9:00 A.M. PT on January 14 and a recording will later be posted on the company’s investor relations website. The information is being provided under Items 2.02 and 7.01 and is designated as furnished rather than filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into other Securities Act or Exchange Act filings.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

Accepted by SEC EDGAR 01/12/2026 - 09:01 AM Learn about SEC filing dates

FAQ

What did Concentra Group Holdings Parent, Inc. (CON) disclose in this 8-K?

The company furnished an investor presentation, attached as Exhibit 99.1, that includes preliminary, unaudited operational metrics for the quarter ended December 31, 2025.

How will Concentra Group (CON) use the preliminary Q4 2025 metrics presentation?

The presentation in Exhibit 99.1 will be delivered at the J.P. Morgan Healthcare Conference at 9:00 A.M. PT on Wednesday, January 14, and a recording will be posted on the company’s investor relations website after the event.

Are the metrics in Concentra Group’s latest presentation audited?

No. The company states that the presentation contains preliminary, unaudited results of certain operational metrics for the quarter ended December 31, 2025.

Is the information in Concentra Group’s Q4 2025 presentation considered filed with the SEC?

No. The company specifies that the information in this report, including Exhibit 99.1, is being furnished under Items 2.02 and 7.01 and is not deemed “filed” for purposes of Section 18 of the Exchange Act.

Where can investors access Concentra Group’s J.P. Morgan Healthcare Conference presentation?

After the conference, a recording of the presentation will be posted on Concentra Group’s investor relations website at https://ir.concentra.com/.

Does Concentra Group include a forward-looking statements disclaimer in this disclosure?

Yes. The company includes a forward-looking statements section noting that statements about future expectations, plans, and prospects are subject to risks described in its Annual Report on Form 10-K for the year ended December 31, 2024 and other SEC filings.

FALSE000201459600020145962026-01-122026-01-12

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 8-K

_______________

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 12, 2026

_______________

CONCENTRA GROUP HOLDINGS PARENT, INC.

(Exact Name of Registrant as Specified in Its Charter)

_______________

001-42188

(Commission File Number)

Delaware			30-1006613
(State or Other Jurisdiction of Incorporation)			(I.R.S. Employer Identification No.)

5080 Spectrum Drive, Suite 1200W

Addison, TX, 75001

(Address of principal executive offices) (Zip code)

(972) 364-8000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value per share

CON

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On January 12, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) published a presentation that includes preliminary, unaudited results of certain operational metrics for the quarter ended December 31, 2025, attached hereto as Exhibit 99.1. The Company will be presenting Exhibit 99.1 at the J.P. Morgan Healthcare Conference at 9:00 A.M. PT on Wednesday, January 14th. A recording of the presentation will be published to the Company’s investor relations website (https://ir.concentra.com/) following the event.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and Item 7.01 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such items be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act.

Item 7.01 Regulation FD Disclosure.

The information contained in Item 2.02 of this Current Report on Form 8-K is hereby incorporated by reference into this Item 7.01.

Forward-Looking Statements

Any statements in this Current Report on Form 8-K or presentation about the Company’s future expectations, plans and prospects, including statements containing the words “believe,” “expect,” “intend,” “may,” “projects,” “will,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the factors as are set forth in the risk factors detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (the “SEC”) on March 3, 2025 and the Company’s other filings with the SEC under the headings “Risk Factors” and “Forward-Looking Statements”. In addition, the forward-looking statements included in this Current Report on Form 8-K or presentation represent the Company’s views as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so except as required by law. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date hereof.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number			Description
99.1			Concentra Group Holdings Parent Inc. Presentation.
104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

						CONCENTRA GROUP HOLDINGS PARENT, INC.
Date: January 12, 2026			By:			/s/ Timothy Ryan
						Timothy Ryan
						Executive Vice President and Chief Legal Counsel